Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study-Reference-Cited by-同舟云学术

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

Published:2010-03 Issue:3 Volume:9 Page:264-272
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Jilek Samantha,Jaquiéry Emilie,Hirsch Hans H,Lysandropoulos Andreas,Canales Mathieu,Guignard Laurence,Schluep Myriam,Pantaleo Giuseppe,Du Pasquier Renaud A

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference41 articles.

1. Immunology of multiple sclerosis;Sospedra;Annu Rev Immunol,2005

2. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab;Steinman;Nat Rev Drug Discov,2005

3. Cutting edge: natalizumab blocks adhesion but not initial contact of human T cells to the blood–brain barrier in vivo in an animal model of multiple sclerosis;Coisne;J Immunol,2009

4. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;Polman;N Engl J Med,2006

5. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors;Egli;J Infect Dis,2009

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides;Neurology Neuroimmunology & Neuroinflammation;2024-05

2. Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis;Drug Safety;2024-02-07

3. Ocrelizumab Impairs the Phenotype and Function of Memory CD8 ⁺ T Cells;Neurology Neuroimmunology & Neuroinflammation;2023-03

4. Advances in Treatment of Progressive Multifocal Leukoencephalopathy;Annals of Neurology;2021-09-07

5. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis;Frontiers in Immunology;2021-07-07